Publication Date:
2011-03-04
Description:
Defined transcription factors can induce epigenetic reprogramming of adult mammalian cells into induced pluripotent stem cells. Although DNA factors are integrated during some reprogramming methods, it is unknown whether the genome remains unchanged at the single nucleotide level. Here we show that 22 human induced pluripotent stem (hiPS) cell lines reprogrammed using five different methods each contained an average of five protein-coding point mutations in the regions sampled (an estimated six protein-coding point mutations per exome). The majority of these mutations were non-synonymous, nonsense or splice variants, and were enriched in genes mutated or having causative effects in cancers. At least half of these reprogramming-associated mutations pre-existed in fibroblast progenitors at low frequencies, whereas the rest occurred during or after reprogramming. Thus, hiPS cells acquire genetic modifications in addition to epigenetic modifications. Extensive genetic screening should become a standard procedure to ensure hiPS cell safety before clinical use.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074107/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉 〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074107/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Gore, Athurva -- Li, Zhe -- Fung, Ho-Lim -- Young, Jessica E -- Agarwal, Suneet -- Antosiewicz-Bourget, Jessica -- Canto, Isabel -- Giorgetti, Alessandra -- Israel, Mason A -- Kiskinis, Evangelos -- Lee, Je-Hyuk -- Loh, Yuin-Han -- Manos, Philip D -- Montserrat, Nuria -- Panopoulos, Athanasia D -- Ruiz, Sergio -- Wilbert, Melissa L -- Yu, Junying -- Kirkness, Ewen F -- Izpisua Belmonte, Juan Carlos -- Rossi, Derrick J -- Thomson, James A -- Eggan, Kevin -- Daley, George Q -- Goldstein, Lawrence S B -- Zhang, Kun -- K08 HL089150/HL/NHLBI NIH HHS/ -- R01 HL094963/HL/NHLBI NIH HHS/ -- R01 HL094963-01/HL/NHLBI NIH HHS/ -- T32 GM008666/GM/NIGMS NIH HHS/ -- U01 HL100001/HL/NHLBI NIH HHS/ -- Howard Hughes Medical Institute/ -- England -- Nature. 2011 Mar 3;471(7336):63-7. doi: 10.1038/nature09805.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Bioengineering, University of California at San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/21368825" target="_blank"〉PubMed〈/a〉
Keywords:
Cells, Cultured
;
Cellular Reprogramming/*genetics
;
DNA Mutational Analysis
;
Epistasis, Genetic/genetics
;
Fibroblasts/cytology/metabolism
;
Humans
;
Induced Pluripotent Stem Cells/cytology/*metabolism
;
Male
;
Middle Aged
;
Models, Genetic
;
Mutagenesis/*genetics
;
Open Reading Frames/genetics
;
Point Mutation/*genetics
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
